புளூஸ்டோன் துணிகர கூட்டாளர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from புளூஸ்டோன் துணிகர கூட்டாளர்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In புளூஸ்டோன் துணிகர கூட்டாளர்கள் Today - Breaking & Trending Today

Genetic Health Information Network Summit Will Address Data and Digital Infrastructure for Precision Medicine


Genetic Health Information Network Summit Will Address Data and Digital Infrastructure for Precision Medicine
News provided by
Share this article
Share this article
NASHVILLE, Tenn., June 10, 2021 /PRNewswire/ Concert Genetics, in collaboration with leaders from across genetics and healthcare, today announced the 4th Genetic Health Information Network Summit will take place October 25-27, 2021, in Nashville, Tenn. This event assembles leaders at the intersection of genetics, technology, and healthcare, to solve the data and digital infrastructure challenges in precision medicine.
Emerging from a global pandemic, it is clearer than ever that the science of genetics and the systems to track and share data must advance to meet the pressing health challenges of the 21st century, said Gillian Hooker, PhD, ScM, LCGC, Chief Scientific Officer of Concert Genetics. We look forward to bringing this group back together to accelerate that advancement in the hopes of e ....

United States , Carlos Bustamante , Phillip Febbo , Priscilla Alfaro , Mara Aspinall , Howard Levy , Robert Nussbaum , Steve Goldberg , Randy Scott , Gillian Hooker , Robert Steiner , Debra Esser , Dax Kurbegov , Nick Tazik , Jim Almas , Health Science , National Institutes Of Health , Sarah Cannon Cancer Institute , Group Vice , Bustamante Lab Inc , University Of Wisconsin , American Medical Association , Genetic Health Information Network Summit , National Human Genome Research Institute , Quest Diagnostics , Affairs Diagnostic Services ,

Elucid Raises $8M in Series A Funding


Elucid Raises $8M in Series A Funding
Elucid, a Boston, MA-based medical technology company developing AI software to enable cardiovascular disease detection, raised $8M in Series A financing.
The round was led by MedTex Ventures and Global Health Impact Fund. New and existing investors Checkmate Capital, IAG Capital, BlueStone Venture Partners, University of Michigan – Wolverine Venture Fund, Willamette Valley Capital LLC, and Angel Physicians Fund also participated in the round.
The company intends to use the funds to to continue advancing its technology for non-invasive estimation of cardiovascular event risk, myocardial ischemia, and therapeutic response.
Led by CEO Blake Richards, Chief Commercial Officer Jason Bottiglieri and Founder, President, and CTO Andrew Buckler, Elucid is a medical technology company using interpretable and validated AI to provide physicians with a means to optimize treatment decisions for patients with known or suspected cardiovas ....

United States , Blake Richards , Jason Bottiglieri , Andrew Buckler , Global Health Impact Fund , Angel Physicians Fund , Wolverine Venture Fund , Willamette Valley Capital , University Of Michigan , Medtex Ventures , Global Health Impact , Checkmate Capital , Bluestone Venture Partners , Chief Commercial Officer Jason Bottiglieri , Lipid Rich Necrotic , ஒன்றுபட்டது மாநிலங்களில் , பிளேக் ரிச்சர்ட்ஸ் , ஆண்ட்ரூ பக்லர் , உலகளாவிய ஆரோக்கியம் தாக்கம் நிதி , தேவதை மருத்துவர்கள் நிதி , வால்வரின் துணிகர நிதி , பல்கலைக்கழகம் ஆஃப் மிச்சிகன் , உலகளாவிய ஆரோக்கியம் தாக்கம் , செக்மேட் மூலதனம் , புளூஸ்டோன் துணிகர கூட்டாளர்கள் ,